MedAssets SG&A Expense Quarterly:
72.36M for March 31, 2013MedAssets Historical SG&A Expense Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 72.36M |
| Dec. 31, 2012 | 66.35M |
| Sept. 30, 2012 | 68.15M |
| June 30, 2012 | 75.75M |
| March 31, 2012 | 68.38M |
| Dec. 31, 2011 | 67.54M |
| Sept. 30, 2011 | 66.05M |
| June 30, 2011 | 64.77M |
| March 31, 2011 | 61.74M |
| Dec. 31, 2010 | 44.34M |
| Sept. 30, 2010 | 37.87M |
| June 30, 2010 | 47.96M |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
MDAS SG&A Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Cerner Corporation | 315.17M |
| Omnicell | 33.24M |
| AthenaHealth | 64.00M |
MDAS SG&A Expense Quarterly Rankings
| Overall |
84th percentile 1229 of 8002 |
| Sector |
82nd percentile 169 of 954 in Technology |
| Industry |
86th percentile 2 of 15 in Health Information Services |
MDAS SG&A Expense Quarterly Range, Past 5 Years
| Minimum | 31.76M | Jun 2008 |
| Maximum | 75.75M | Jun 2012 |
| Average | 52.04M |
MDAS News
Jeff Surges, CEO of Merge Healthcare Incorporated (MRGE), Interviews with The Wall Street Transcript
Wall Street Transcript May 16
Wall Street Transcript May 16